Edition:
United States

Respiri Ltd (RSH.AX)

RSH.AX on Australia Stock Exchange

0.05AUD
2 Dec 2016
Change (% chg)

-- (--)
Prev Close
$0.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
291,550
52-wk High
$0.08
52-wk Low
$0.03

Summary

Name Age Since Current Position

Leon L'Huillier

2014 Chairman of the Board

David Model

2011 Senior Vice President - Finance

Phillip Hains

2006 Joint Company Secretary

Peter Vaughan

2011 Joint Company Secretary

Timothy Oldham

2014 Non-Executive Director

John Ribot-de-Bresac

2014 Non-Executive Director

Biographies

Name Description

Leon L'Huillier

Mr. Leon Michael L'Huillier is Chairman of the Board of Isonea Ltd effective February 4, 2014. Leon is an experienced chairman and company director with a background in health, retail and consumer goods and private equity. Leon is a former director of Woolworths and chairman of its audit and risk management committee. Currently he is a deputy chairman of Australian Prostate Cancer Research, a former chairman of the Australian Health Ministers Advisory Council, The Royal Children’s Hospital Brisbane and a former director of St. Vincent’s Hospital Melbourne and The Bernard O’Brien Institute of Microsurgery. He has also been a director of private equity in association with Archer Capital, Gresham, and Macquarie Bank.

David Model

Phillip Hains

Mr. Phillip Hains has been Joint Company Secretary of Isonea Ltd since November 21, 2006. He is a Chartered Accountant and specialist in the public company environment. He has served the needs of a number of public company boards of directors and related committees. He has over 20 years experience in providing accounting, administration, compliance and general management services. He holds a Masters of Business Administration from RMIT and a Public Practice Certificate from the Institute of Chartered Accountants.

Peter Vaughan

Mr. Peter Vaughan has been Joint Company Secretary of Isonea Ltd since October 5, 2011. Mr. Vaughan is a Chartered Accountant who has worked in the listed company environment for almost 10 years across a number of industries. He has served on and provided accounting, administration, compliance and general management services to a number of private, not-for-profit and public company boards of directors and related committees.

Timothy Oldham

Dr. Timothy (Tim) Charles Oldham is Non-Executive Director of Isonea Ltd effective January 6, 2014. Dr. Oldham has more than a decade of direct life sciences business development, alliance management, market entry, and sales & marketing experience in Europe, Asia and Australia including as President of Asia Pacific for Hospira, Inc. (2007 to 2012), and a variety of senior management roles with Mayne Pharma (2002 to 2007) prior to its acquisition by Hospira. These roles encompassed the development and commercialisation of pharmaceuticals, devices and biologics. Prior to this, he was an engagement manager with McKinsey & Co (1997 to 2001). Dr. Oldham has been chairman of the European Generic Medicines Association Biosimilars and Biotechnology Committee, a director of the Generic Medicines Industry Association and a member of the Pharmaceutical Industry Strategy Group. He is a also a Director of Acrux Ltd (ASX:ACR).

John Ribot-de-Bresac

Mr. John Ribot-de-Bresac is Non-Executive Director of Isonea Ltd effective February 4, 2014. He has experience and a record of achievement as a senior executive across the sport, leisure and hospitality industries including in strategy development and implementation. Following a distinguished sports career where he received the Australian Sports Medal, he was involved in the establishment of the Brisbane Broncos and Melbourne Storm, in executive director roles, and as chairman of the Brisbane Roar. Currently John serves as director of Victorian Major Events Company, executive chairman of Queensland Clubs Management (QCM), and owns hospitality venues throughout Queensland.

Basic Compensation

Name Fiscal Year Total

Leon L'Huillier

--

David Model

133,354

Phillip Hains

--

Peter Vaughan

--

Timothy Oldham

--

John Ribot-de-Bresac

--
As Of  29 Jun 2013